Loading...
Please wait, while we are loading the content...
Similar Documents
Association of British Clinical Diabetologists (ABCD) and Renal Association clinical guidelines: Hypertension management and renin-angiotensin-aldosterone system blockade in patients with diabetes, nephropathy and/or chronic kidney disease
| Content Provider | Semantic Scholar |
|---|---|
| Author | Dasgupta, Indranil Banerjee, Debasish Chowdhury, T. A. De, Parijat Wahba, Mona Bain, Stephen C. Frankel, Andrew Fogarty, Damian Pokrajac, Ana Winocour, Peter D. |
| Copyright Year | 2017 |
| Abstract | Diabetes is the commonest cause of end-stage renal disease; over a quarter of patients who are on dialysis in the UK have diabetes. Diabetic kidney disease is associated with high cardiovascular morbidity and mortality. Hypertension is a modifiable risk factor for cardiovascular complications and progression of diabetic kidney disease. The Association of British Clinical Diabetologists and the Renal Association have jointly developed guidelines for management of hypertension through different stages of diabetic kidney disease. Here we present a summary of clinical practice recommendations, audit standards, and areas that require further research. |
| Starting Page | 160 |
| Ending Page | 164 |
| Page Count | 5 |
| File Format | PDF HTM / HTML |
| DOI | 10.15277/bjd.2017.152 |
| Alternate Webpage(s) | http://www.diabetologists-abcd.org.uk/Position_Papers/ABCDRA_BP_guidelines_summary_2017.pdf |
| Alternate Webpage(s) | https://bjd-abcd.com/index.php/bjd/article/download/276/448 |
| Alternate Webpage(s) | https://doi.org/10.15277/bjd.2017.152 |
| Volume Number | 17 |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
